<?xml version="1.0" encoding="UTF-8"?>
<collection xmlns="http://www.loc.gov/MARC21/slim">
 <record>
  <leader>     caa a22        4500</leader>
  <controlfield tag="001">445885424</controlfield>
  <controlfield tag="003">CHVBK</controlfield>
  <controlfield tag="005">20180317145558.0</controlfield>
  <controlfield tag="007">cr unu---uuuuu</controlfield>
  <controlfield tag="008">170323e20110301xx      s     000 0 eng  </controlfield>
  <datafield tag="024" ind1="7" ind2="0">
   <subfield code="a">10.1007/s00011-010-0264-7</subfield>
   <subfield code="2">doi</subfield>
  </datafield>
  <datafield tag="035" ind1=" " ind2=" ">
   <subfield code="a">(NATIONALLICENCE)springer-10.1007/s00011-010-0264-7</subfield>
  </datafield>
  <datafield tag="245" ind1="0" ind2="0">
   <subfield code="a">Blood lymphocyte blastogenesis in patients with thyroid dysfunction: exvivo response to mitogen activation and cyclosporinA</subfield>
   <subfield code="h">[Elektronische Daten]</subfield>
   <subfield code="c">[Garyphallia Papaioannou, Fotios Michelis, Konstantinos Papamichael, Helen Karga, Ekaterini Tiligada]</subfield>
  </datafield>
  <datafield tag="520" ind1="3" ind2=" ">
   <subfield code="a">Objective: To evaluate lymphocyte activation following mitogen and cyclosporinA (CsA) administration in peripheral blood of hyperthyroxinaemic and hypothyroid patients. Materials and methods: Lymphocyte activation was evaluated by determining blastogenesis in 48h cultured blood lymphocytes obtained from eight hyperthyroxinaemic and eight hypothyroid patients, following phytohaemagglutinin (PHA)-induced stimulation in the absence or presence of CsA. Twelve healthy volunteers served as controls. Results and conclusions: Lymphocytes from hypothyroid patients exhibited reduced response to PHA and lower sensitivity to CsA compared with control, which could be attributed to their reduced activation capability coexisting with hypothyroidism. In hyperthyroxinaemic samples, the actions of high CsA concentrations were mostly targeted toward activated lymphoblasts. Considering the cellular targets that thyroid hormones and CsA may share, the therapeutic implications of their cross-talk need careful consideration.</subfield>
  </datafield>
  <datafield tag="540" ind1=" " ind2=" ">
   <subfield code="a">Springer Basel AG, 2010</subfield>
  </datafield>
  <datafield tag="690" ind1=" " ind2="7">
   <subfield code="a">Blastogenesis</subfield>
   <subfield code="2">nationallicence</subfield>
  </datafield>
  <datafield tag="690" ind1=" " ind2="7">
   <subfield code="a">Cyclosporine</subfield>
   <subfield code="2">nationallicence</subfield>
  </datafield>
  <datafield tag="690" ind1=" " ind2="7">
   <subfield code="a">Lymphocytes</subfield>
   <subfield code="2">nationallicence</subfield>
  </datafield>
  <datafield tag="690" ind1=" " ind2="7">
   <subfield code="a">Patients</subfield>
   <subfield code="2">nationallicence</subfield>
  </datafield>
  <datafield tag="690" ind1=" " ind2="7">
   <subfield code="a">Thyroid hormones</subfield>
   <subfield code="2">nationallicence</subfield>
  </datafield>
  <datafield tag="700" ind1="1" ind2=" ">
   <subfield code="a">Papaioannou</subfield>
   <subfield code="D">Garyphallia</subfield>
   <subfield code="u">Department of Pharmacology, Medical School, University of Athens, M. Asias 75, 11527, Athens, Greece</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="700" ind1="1" ind2=" ">
   <subfield code="a">Michelis</subfield>
   <subfield code="D">Fotios</subfield>
   <subfield code="u">Department of Pharmacology, Medical School, University of Athens, M. Asias 75, 11527, Athens, Greece</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="700" ind1="1" ind2=" ">
   <subfield code="a">Papamichael</subfield>
   <subfield code="D">Konstantinos</subfield>
   <subfield code="u">Department of Pharmacology, Medical School, University of Athens, M. Asias 75, 11527, Athens, Greece</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="700" ind1="1" ind2=" ">
   <subfield code="a">Karga</subfield>
   <subfield code="D">Helen</subfield>
   <subfield code="u">Second Division of Endocrinology, Alexandra Hospital, Athens, Greece</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="700" ind1="1" ind2=" ">
   <subfield code="a">Tiligada</subfield>
   <subfield code="D">Ekaterini</subfield>
   <subfield code="u">Department of Pharmacology, Medical School, University of Athens, M. Asias 75, 11527, Athens, Greece</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="773" ind1="0" ind2=" ">
   <subfield code="t">Inflammation Research</subfield>
   <subfield code="d">SP Birkhäuser Verlag Basel</subfield>
   <subfield code="g">60/3(2011-03-01), 265-270</subfield>
   <subfield code="x">1023-3830</subfield>
   <subfield code="q">60:3&lt;265</subfield>
   <subfield code="1">2011</subfield>
   <subfield code="2">60</subfield>
   <subfield code="o">11</subfield>
  </datafield>
  <datafield tag="856" ind1="4" ind2="0">
   <subfield code="u">https://doi.org/10.1007/s00011-010-0264-7</subfield>
   <subfield code="q">text/html</subfield>
   <subfield code="z">Onlinezugriff via DOI</subfield>
  </datafield>
  <datafield tag="908" ind1=" " ind2=" ">
   <subfield code="D">1</subfield>
   <subfield code="a">research-article</subfield>
   <subfield code="2">jats</subfield>
  </datafield>
  <datafield tag="950" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="P">856</subfield>
   <subfield code="E">40</subfield>
   <subfield code="u">https://doi.org/10.1007/s00011-010-0264-7</subfield>
   <subfield code="q">text/html</subfield>
   <subfield code="z">Onlinezugriff via DOI</subfield>
  </datafield>
  <datafield tag="950" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="P">700</subfield>
   <subfield code="E">1-</subfield>
   <subfield code="a">Papaioannou</subfield>
   <subfield code="D">Garyphallia</subfield>
   <subfield code="u">Department of Pharmacology, Medical School, University of Athens, M. Asias 75, 11527, Athens, Greece</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="950" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="P">700</subfield>
   <subfield code="E">1-</subfield>
   <subfield code="a">Michelis</subfield>
   <subfield code="D">Fotios</subfield>
   <subfield code="u">Department of Pharmacology, Medical School, University of Athens, M. Asias 75, 11527, Athens, Greece</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="950" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="P">700</subfield>
   <subfield code="E">1-</subfield>
   <subfield code="a">Papamichael</subfield>
   <subfield code="D">Konstantinos</subfield>
   <subfield code="u">Department of Pharmacology, Medical School, University of Athens, M. Asias 75, 11527, Athens, Greece</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="950" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="P">700</subfield>
   <subfield code="E">1-</subfield>
   <subfield code="a">Karga</subfield>
   <subfield code="D">Helen</subfield>
   <subfield code="u">Second Division of Endocrinology, Alexandra Hospital, Athens, Greece</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="950" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="P">700</subfield>
   <subfield code="E">1-</subfield>
   <subfield code="a">Tiligada</subfield>
   <subfield code="D">Ekaterini</subfield>
   <subfield code="u">Department of Pharmacology, Medical School, University of Athens, M. Asias 75, 11527, Athens, Greece</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="950" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="P">773</subfield>
   <subfield code="E">0-</subfield>
   <subfield code="t">Inflammation Research</subfield>
   <subfield code="d">SP Birkhäuser Verlag Basel</subfield>
   <subfield code="g">60/3(2011-03-01), 265-270</subfield>
   <subfield code="x">1023-3830</subfield>
   <subfield code="q">60:3&lt;265</subfield>
   <subfield code="1">2011</subfield>
   <subfield code="2">60</subfield>
   <subfield code="o">11</subfield>
  </datafield>
  <datafield tag="900" ind1=" " ind2="7">
   <subfield code="a">Metadata rights reserved</subfield>
   <subfield code="b">Springer special CC-BY-NC licence</subfield>
   <subfield code="2">nationallicence</subfield>
  </datafield>
  <datafield tag="898" ind1=" " ind2=" ">
   <subfield code="a">BK010053</subfield>
   <subfield code="b">XK010053</subfield>
   <subfield code="c">XK010000</subfield>
  </datafield>
  <datafield tag="949" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="F">NATIONALLICENCE</subfield>
   <subfield code="b">NL-springer</subfield>
  </datafield>
 </record>
</collection>
